prenetics.com (PRE): Rasio utang jangka dawa marang modal

Lambang korporat lan logo Prenetics Global Limited (PRE)

Prenetics Global (PRE) is a leading player in the Asian genomic research market, offering affordable DNA tests and digital services for early diagnosis. The company is currently optimizing expenses and focusing on the organic growth of its software, while the price action shown below reflects a value of 0.00. Business stability is underpinned by centers in the UK and Hong Kong that implement advanced methods of preventive medicine.

PRE - Utang jangka dawa marang ekuitas Prenetics ing rentang 28.04.2023 - 28.10.2026
Produk merek Prenetics Global Ltd

Prenetics Global's development in personalized medicine and genetics requires significant capital expenditures in diagnostic technologies and the expansion of its Asian network. The dynamics of the long-term debt-to-equity ratio reflect the proportion between long-term liabilities and the market value of shares, demonstrating the balance of interests between creditors and business owners. A decrease in this metric may indicate either financial stability or a stagnation of investment in expansion.

Pesaing langsung

Kewajiban jangka dawa marang modal Agilent Technologies, Inc.|Utang jangka dawa marang modal Quest DGX|Rasio utang jangka dawa marang modal Illumina Platform (ILMN)|Utang jangka dawa marang modal EXAS (Exact Sciences)|revvity.com - Utang jangka dawa marang modal|Bio-Rad (BIO) - Utang jangka dawa marang ekuitas|NNNN - Rasio utang jangka dawa marang modal|SHC: Utang jangka dawa marang modal|QDEL (QuidelOrtho Inc.) - Utang jangka dawa marang modal|Utang jangka dawa marang ekuitas OPKO Health, Inc.|Utang jangka dawa marang ekuitas CareDx Corp (CDNA)|Maravai LifeSciences Holdings, Inc. - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal FLGT (Fulgent Genetics Inc)|Utang jangka dawa marang ekuitas LAB|Rasio tanggungan utang jangka dawa marang modal Cytek Corp CTKB|Utang jangka dawa marang modal OSUR (OraSure Technologies)|XGN: Rasio tanggungan utang jangka dawa marang modal|MDxHealth - Utang jangka dawa marang ekuitas|LUCD (Lucid Diagnostics, Inc.) - Rasio tanggungan utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Insight Molecular Diagnostics, Inc. IMDX|Kewajiban jangka dawa marang ekuitas TRIB|ProPhase Labs, Inc. (PRPH) - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal ainos.com (AIMD)|CODX: Utang jangka dawa marang modal|Heart Test Laboratories, Inc. - Kewajiban jangka dawa marang modal|Biomerica, Inc (BMRA) - Utang jangka dawa marang ekuitas|CDIO - Rasio utang jangka dawa marang modal|Utang jangka dawa marang modal VRAX|Kewajiban jangka dawa marang modal bluejaydx.com|Aspira Women's Health Inc. (AWH) - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka dawa marang modal Accelerate Diagnostics Inc.|CNTG (CENTOGENE, N.V.) - Utang jangka dawa marang modal|Rasio tanggungan utang jangka dawa marang modal enzo.com (ENZ)|Fresh2 Group - Utang jangka dawa marang modal|Genetic Technologies Ltd - Rasio utang jangka dawa marang ekuitas|Utang jangka dawa marang ekuitas ME (23andMe)|Psychemedics Corp. (PMD) - Rasio tanggungan utang jangka dawa marang modal